The UTI Drugs Market is benefiting from continued demand for antibiotics such as nitrofurantoin, fosfomycin, trimethoprim-sulfamethoxazole, and selected cephalosporins. These medicines are used according to infection severity, patient characteristics, and local antimicrobial susceptibility patterns.
The UTI drugs market size is expected to reach US$ 12,959 million by 2031, registering a CAGR...